TLX - Telix
Market cap:around $1B
Biotech focusing on oncology. Has a number of different fields with prostate being most advance and also brain (gbm), renal and bone marrow/rare diseases. They do both diagnosis and treatment. A good quality biotech imo (hence the $1b market cap) with near term results due from a Phase I trial plus a mid cycle meeting with FDA for their Phase III prostate trial. They have a regular news flow with trials starting, patients being enrolled, new partnerships etc. TLX has a global focus with studies in the US, Europe, Asia, Australia etc. At the moment, it is sitting just below a significant retracement level as well as a solid support/resistance level of $3.80. I think it's a good buy at the current level of $3.71 but I'm not tipping it because I'm not confident of it making 25% in 28 days. However, I am confident that it's a solid company and I expect it to be at least double the price by year end. They have an extensive pipeline of imaging and therapy products and should have a commercial product before year end.
- Forums
- ASX - Short Term Trading
- Short Term Trading Weekend Lounge: 5 - 7 Mar
Short Term Trading Weekend Lounge: 5 - 7 Mar, page-15
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online